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ABSTRACT
Objectives Currently available fetal intervention tech-
niques rely on invasive procedures that carry inherent
risks. A non-invasive technique for fetal intervention could
potentially reduce the risk of fetal and obstetric complica-
tions. Pulsed cavitational ultrasound therapy (histotripsy)
is an ablation technique that mechanically fractionates
tissue at the focal region using extracorporeal ultrasound.
In this study, we investigated the feasibility of using his-
totripsy as a non-invasive approach to fetal intervention
in a sheep model.
Methods The experiments involved 11 gravid sheep at
102–129 days of gestation. Fetal kidney, liver, lung
and heart were exposed to ultrasound pulses (< 10 µs)
delivered by an external 1-MHz focused ultrasound
transducer at a 0.2–1-kHz pulse-repetition rate and
10–16 MPa peak negative pressure. Procedures were
monitored and guided by real-time ultrasound imaging.
Treated organs were examined by gross and histological
inspection for location and degree of tissue injury.
Results Hyperechoic, cavitating bubble clouds were
successfully generated in 19/31 (61%) treatment attempts
in 27 fetal organs beneath up to 8 cm of overlying
tissue and fetal bones. Histological assessment confirmed
lesion locations and sizes corresponding to regions where
cavitation was monitored, with no lesions found when
cavitation was absent. Inability to generate cavitation
was primarily associated with increased depth to target
and obstructing structures such as fetal limbs.
Conclusion Extracorporeal histotripsy therapy success-
fully created targeted lesions in fetal sheep organs without
significant damage to overlying structures. With further
improvements, histotripsy may evolve into a viable tech-
nique for non-invasive fetal intervention procedures.
Copyright  2011 ISUOG. Published by John Wiley
& Sons, Ltd.
INTRODUCTION
Congenital abnormalities are the leading cause of infant
mortality in the USA, accounting for more than 20%
of all infant deaths1. Many of these anomalies require
invasive surgery after birth; however, some conditions are
amenable to fetal intervention procedures, which may be
able to prevent disease progression or worsening of the
fetal condition2,3. Currently available fetal treatments for
congenital abnormalities include percutaneous balloon
atrial septoplasty in hypoplastic left heart syndrome with
restrictive atrial septum4, fetoscopic obliteration of blood
vessels in twin–twin transfusion syndrome5 and open
surgical debulking for rapidly growing fetal masses6.
However, preterm labor, infection and premature rupture
of membranes remain as risk factors with even minimally
invasive procedures. Physical and practical limitations
such as fetal size and the adequacy of available equipment
exist for current approaches; this limits the timing of
interventions and likely affects their success. Non-invasive
interventional techniques, such as therapeutic ultrasound,
may reduce risk for both mother and fetus while possibly
allowing earlier intervention options which may have a
greater impact on disease progression, and potentially
yield improved outcomes.
Fetal interventions in animal models have been
reported using high-intensity focused ultrasound (HIFU)
as a thermal ablation method7,8. Histotripsy is a form
of focused ultrasound therapy based on a different
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mechanism in which high-intensity ultrasound pulses are
applied to create controlled cavitation bubble clouds at the
treatment focus. Through the rapid growth and collapse
of the bubbles, targeted tissue is mechanically fractionated
into subcellular debris9,10. The initiation of the cavitation
process is a threshold phenomenon, with bubble clouds
generated only when the focal acoustic pressure exceeds
a certain level11. The hyperechoic nature of the cavitation
bubbles permits the real-time monitoring of therapy
progression using conventional ultrasound imaging, and
resulting lesions are limited to the focal zones where
the cavitating bubble clouds were generated. Previous
experiments in adult or neonatal animals have shown that
histotripsy can efficiently and accurately fractionate and
remove tissue from heart12,13, kidney14 and prostate15
in vivo. The purpose of this study was to demonstrate,
for the first time, the feasibility of applying histotripsy to
non-invasively create localized lesions in fetal organs in a
sheep model.
MATERIALS AND METHODS
Experiments involved 11 gravid ewes, median gesta-
tion 115 days, range 102–129 days (full ovine gestation:
150 days) with 15 fetuses. Each ewe was first sedated with
an intramuscular injection of diazepam (0.5–1 mL/kg)
and intravenous propofol (4–6 mL/kg), followed by endo-
tracheal intubation and inhalation of 1–3% isoflurane
gas. Vital signs were monitored throughout the experi-
ment. All procedures were reviewed and approved by the
University Committee on Use and Care of Animals at the
University of Michigan.
Once the ewe was anesthetized and secured on the
table, the abdomen was shaved and a depilatory cream
was applied to remove any remaining wool and improve
ultrasound coupling. Preliminary ultrasound imaging was
performed using a clinical ultrasound imaging system
(Sonos 7500, Philips Electronics, Andover, MA, USA)
with a 5-MHz curvilinear imaging probe (Model c3540,
Philips Electronics) to determine the number and lie of
the fetuses. The ewe was then positioned on her side or
back to optimize acoustic windows for fetal targeting.
A 1-MHz focused ultrasonic transducer (Imasonic,
Besançon, France) with an aperture of 100 mm and
focal length of 90 mm was used as the therapeutic
unit. To monitor the treatment, a 3-MHz phased array
ultrasonic imaging probe (Model S3, Philips Electronics)
was coaxially aligned through a center hole in the
therapy transducer specifically designed to accommodate
the probe. The focal location of the transducer with
respect to the imaging probe’s field of view was found
prior to treatment by generating a cavitation cloud
in degassed water and highlighting the region where
hyperechoic activity was observed on the imaging screen.
Following this procedure, a metal bowl with a center
opening lined with clear plastic was coupled to the ewe’s
abdomen using LithoClear acoustic transmission gel
(Sonotech, Inc., Bellingham, WA, USA), and filled with
degassed water. This set-up allowed continued ultrasound
coupling through water even when the transducer (with a
fixed focal distance) was centimeters above the maternal
abdomen to target shallower targets. Degassed water was
used to minimize the formation of reflective gas bubbles
at the skin interface. The transducer unit was secured to
a three-axis motorized system (Parker Hannifin, Rohnert
Park, CA, USA) and positioned within the water bowl
to place the transducer’s focus on the targeted organ
(Figure 1).
Sheep were exposed to 1-MHz ultrasound pulses
with measured free-field peak rarefactional pressures of
10–16 MPa. The ultrasound pulses were 5 µs in duration
(five cycles at 1 MHz) and separated by 1–5 ms (i.e. pulse
repetition frequencies of 200 Hz to 1 kHz). The formation
of a highly echogenic cavitation bubble cloud at the focus
of the transducer during treatment allowed procedures














Figure 1 Diagram of the side view and photograph from above of the experimental set-up.
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cloud serving the dual purpose of a tissue fractionation
agent and a reference point for treatment guidance. 2D
and color Doppler ultrasound imaging were used to follow
the treatment and determine its effectiveness. Fetal kidney,
liver, lung and heart were targeted at depths ranging from
2 to 8 cm from the maternal abdominal wall. In fetal
kidney, liver and lung, cubic tissue volumes (0.1–1 cm3)
were targeted by mechanically scanning the focus of the
therapeutic transducer through a 3D grid of points during
ultrasound exposure, with each point treated for ∼ 2 s and
adjacent points separated by 0.5–1.5 mm. In fetal hearts,
single-focus lesions were created by targeting individual
spots from 30 to 80 s.
Following the intervention, the ewes were euthanized
with pentobarbital. The fetuses were harvested and
visually inspected for any signs of collateral damage near
the targeted fetal organs. Targeted organs were removed
and evaluated by gross examination, with samples stained
with hematoxylin and eosin (H&E) for histological
analysis by a pathologist (J.E.W.).
RESULTS
A total of 19 of 31 treatment attempts resulted in the
successful generation of a cavitation cloud at the target,
with lesions observed in 17 of the 19 cases in which
cavitation was generated (Table 1). Fetal kidney, liver and
heart were primary targets, with fetal lungs treated on two
occasions. Morphological and histological examination
confirmed that lesions were generated at the sites where
cavitation had been visualized on ultrasound imaging. No
lesions were observed in targets where cavitation clouds
were absent.
Cases with cavitating bubble cloud generation
Fetal kidney, liver and lung
Cavitating bubble clouds were observed in five of five
treatments in kidney, five of nine treatments in liver and
two of two treatments in lung, generating identifiable
Table 1 Results of 31 attempts of pulsed cavitational ultrasound















Kidney 3.6 (2.7–5.6) 5/5 (100) 5/5 (100)
Liver 6.4 (2.4–8.2) 5/9 (56) 3/5 (60)
Lung 6.4 (5.8–7.0) 2/2 (100) 2/2 (100)
Heart 7.2 (3.9–8.2) 7/15 (47) 7/7 (100)
Overall 6.5 (2.4–8.2) 19/31 (61) 17/19 (89)
Data are given as median (range) or n (%).
lesions in five kidneys, three livers and two lungs. In
real time, the bubble clouds could be identified by their
bright, flickering pattern, which was distinguishable from
surrounding structures. The bubble clouds appeared as
3–4-mm-wide hyperechoic zones at the geometric focus
of the transducer by 2D ultrasound imaging (Figure 2).
On one occasion, the same liver was treated twice, with
only one larger lesion found; the targeting locations of the
two treatments were close enough that they likely formed
a contiguous treated area which appeared as a single
lesion. With the exception of one liver sample in which no
clear signs of damage were encountered after treatment,
lesions were present in all targets where cavitation bubble
clouds were successfully generated.
Morphological inspection of fixed samples showed
darkened hemorrhagic regions corresponding to the loca-
tions where the cavitation bubble clouds had been
observed, with affected areas comparable in size to
the dimensions of regions scanned during treatment
(Figure 3a,d). Hemorrhage effects were noted to be more
pronounced in the kidney than in other organs. Histolog-
ical analysis revealed cellular destruction accompanied by
hemorrhage within the treated area in the kidney and liver
(Figure 3b,c,e,f), with similar lesion patterns observed in
the lung (not shown). The damaged regions were filled
with red blood cells, acellular debris and, in certain cases,
Figure 2 Two-dimensional ultrasound images of a fetal kidney (a) and liver (b) during therapeutic ultrasound exposure. Cavitation bubble
clouds were created at the focus of the therapeutic transducer (arrows). The high-intensity pulses originating from the therapeutic transducer
caused visible radial interference patterns in both images.
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Figure 3 Representative pathology and histology pictures of a fetal kidney (a–c) and liver (d–f) treated by pulsed cavitational ultrasound.
The dark regions indicated by the ellipses correspond to lesion areas created by mechanically scanning the treatment focus (a and d).
Histological examination revealed interspersed hemorrhagic spots in both kidney and liver (b and e). Damaged areas consisted of a variable
combination of red blood cells, subcellular debris and intact tissue cells (c and f).
isolated islands of intact cells. The degree of cellular
disruption in the lesions varied from case to case, rang-
ing from total loss of all normal tissue architecture and
structures to primarily hemorrhage with the majority of
cellular structures physically intact.
Fetal heart
Cavitation bubble clouds were successfully generated at
the focus in seven of 15 fetal heart treatments. A total
of seven targeted single focus lesions were verified by
pathology: five in the ventricular septum and two in the
ventricular wall. The ventricular free wall was specifically
targeted in cases where the ventricular septum was deeper
in the maternal abdomen than reachable by the focal zone
of the therapy transducer.
In one case, a lesion created in the ventricular septum
perforated the septum and resulted in a ventricular
septal defect (VSD), confirmed by 2D and color Doppler
echocardiography (Figure 4). Transient fetal bradycardia
was observed during several treatments, but resolved
spontaneously with cessation of treatment. In two
separate cases, heart function ceased a few minutes after
treatment. On both occasions, a cavitation cloud had been
sustained for prolonged periods of time (60 s or more) in
the basal portion of the heart, possibly in the vicinity of
the atrioventricular node.
Morphology revealed discolored myocardium at sites
where cavitating bubble clouds had been present. Lesions
created in the ventricular septum were ∼ 2–3 mm in
diameter, corresponding to the diameter of the cavitation
cloud. A small amount of hemorrhage on the exterior of
the ventricular wall was observed in two of three fetal
hearts where the ventricular septum had been targeted.
In one case (not the VSD case), however, precise lesions
were created in the ventricular septum while the heart’s
exterior remained intact with no damage visible outside
the targeted region (Figure 5a,b). In treatments where the
ventricular wall was targeted, lesions were accompanied
by the presence of substantial superficial hemorrhage on
the pericardium (Figure 5c,d).
Histological evaluation of the ventricular septum
lesions showed complete fractionation of the septal tissue
at the site of treatment with moderate amounts of
free blood in the lesion (Figure 6a,b). The myocardial
structure was completely lost in the majority of cases,
with lesions characterized by sharp margins. Most of the
defect was lined by eosinophilic, contracted myocytes,
flanked by normal myocardium. In a few areas, there
was a thin rim of cellular debris between the blood
and the myocardium. Lesions created on the ventricular
free wall were generally characterized by significant
hemorrhage and cellular ablation (Figure 6c,d). In many
areas, blood surrounded clusters of intact cardiomyocytes.
Other areas had considerable cellular debris between the
blood and the intact myocardium. Lesions that were
less penetrating nevertheless consisted of hemorrhage
and significant cellular destruction. Hemorrhage into the
myocardial interstitium was occasionally present. The
mildest lesions consisted of epicardial hemorrhage with
small focal areas of cellular debris between the free blood
and the myocardium.
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Figure 4 (a) Pretreatment color Doppler image of the fetal heart, showing an intact ventricular septum (VS). (b) A cavitation bubble cloud is
seen as a hyperechoic zone during histotripsy application, as indicated by the arrow. (c) Post-treatment color Doppler image of the fetal
heart. The creation of a ventricular septal defect (VSD) allows a flow channel between the left ventricle (LV) and the right ventricle (RV).
Figure 5 (a, b) A fetal heart in which the ventricular septum was targeted. (a) External view with intact exterior. (b) A longitudinal section of
the heart revealed two lesions, created in the ventricular septum after 30 and 60 s of exposure (indicated by the arrows), of ∼ 2 and 3 mm in
diameter, respectively. The lesion edges were well defined within the ventricular septum, without noticeable damage outside this area. (c, d)
Sample heart in which the ventricular wall was targeted. (c) Substantial superficial hemorrhage was present on the heart wall. (d) A lesion
3 mm in diameter (arrow) was generated after 80 s of treatment.
Cases without cavitating bubble cloud generation
Three factors were associated with the inability to generate
a cavitating bubble cloud at the focus: depth of the target
organ, acoustic obstruction by fetal limbs and the presence
of prefocal cavitation (Table 2). A cavitating cloud was
generated in 100% (6/6) of fetal targets < 4 cm from
the maternal abdominal surface (Figure 7); in targets
> 4 cm from the maternal abdominal surface, the success
rate for generation of a bubble cloud was only 52%
(13/25, P = 0.06). A fetal extremity was in the path of the
ultrasound beam in 67% (8/12) of cases with unsuccessful
generation of a cavitating cloud, but only 21% (4/19) of
cases with successful cavitation generation (P = 0.03). In
Copyright  2011 ISUOG. Published by John Wiley & Sons, Ltd. Ultrasound Obstet Gynecol 2011; 37: 450–457.
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Figure 6 (a, b) Hematoxylin and eosin slides of a lesion created in the ventricular septum at × 2 (a) and × 20 (b) original magnification.
(a) The darker area corresponds to residual blood from the ventricle that has coagulated inside the lesion cavity, which spanned almost the
entire septum. (b) Fractionated areas were characterized by distinct boundaries. (c, d) Lesions created on the heart wall were accompanied
by epicardial hemorrhage with mild tissue destruction, here shown at × 2 (c) and × 20 (d) original magnification.






(n = 12) P*
Gestational age (days) 112 (102–129) 119 (108–129) 0.76







Spine up 9 2
Spine down 3 4
Right side up 1 4
Left side up 6 2
Obstructing structure† 7 10 0.05
Obstructing fetal limbs 4 8 0.03
Prefocal cavitation 7 9 0.04
Data are given as median (range) or n. *Mann–Whitney U test for
categorical variables or Fisher’s exact test for continuous variables.
†Umbilical cord, placenta and fetal limbs.
52% (16/31) of the treatment cases, varying amounts of
prefocal cavitation were observed at the fetal skin and





























Figure 7 Incidence of focal cavitation according to target depth.
Successful (ž) and unsuccessful (°) attempts are shown.Horizontal lines indicate the median depth of each distribution.
ultrasound energy from reaching the target. This effect
was observed in 75% (9/12) of cases in which a bubble
cloud could not be generated at the focus and in 37%
(7/19) of cases in which a cloud was successfully generated
(P = 0.04). In general, short-lived prefocal cavitation did
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not create any visible damage to fetal tissues, but in a few
lambs, longer and more intense occurrences caused partial
discoloration on the fetal skin, possibly due to superficial
hemorrhage.
DISCUSSION
In this study, extracorporeal histotripsy was used to
successfully generate lesions in fetal targets. Treatment
was guided by a temporally changing, hyperechoic
cavitation bubble cloud at the site of lesion generation,
which was monitored by ultrasound imaging.
Multiple fetal anomalies could benefit from a non-
invasive, precise method of tissue destruction. Possible
clinical applications in the human fetus include de-bulking
of solid masses causing compression of vital structures or
fetal distress, cardiac interventions such as creation of
atrial septal defects or perforation of atretic valves, and
selective reduction of multiple gestations via direct target-
ing of the fetal heart. In addition, given that significant
bleeding has not been observed in other models after
histotripsy therapy of vascular organs14, even vascular
structures and/or malformations (i.e. teratomas or com-
municating vessels in twin–twin transfusion syndrome
and twin reversed arterial perfusion syndrome) could be
clinical targets. Furthermore, previous studies have shown
that high-intensity focused ultrasound can induce coag-
ulation and hemostasis through thermal and cavitational
means16,17.
Histotripsy was successful in creating lesions in 17 of
31 treatment attempts. In kidney, liver and lung, the
size of the affected regions was comparable with the
dimensions of the treatment scan. There was increased
flanking hemorrhage in the kidney, perhaps due to its
high vascularity; however, ongoing studies show that
hemorrhage and flanking injury induced by histotripsy
recover within 1 month in neonatal porcine hearts (G.E.
Owens, personal communication, June 17, 2010). The
degree of cellular disruption in the lesions varied from
total loss of all normal tissue architecture to primarily
hemorrhage. This variability could be attributed to
different levels of acoustic aberration and attenuation
from fetal bone and tissue in each experiment. In heart
treatments, 2–3-mm lesions separated by < 1 cm were
generated within the fetal ventricular septum. Considering
that the ultrasound beam had to traverse up to 8 cm of
overlying tissue, this targeting accuracy surpassed our
initial expectations, but still needs further refinement in
order to improve consistency and to optimize ultrasound
parameters for maximal tissue removal, which was not
done in this feasibility study.
Because treatment accuracy is determined by the
cavitation bubble cloud size at the target, which
depends on acoustic parameters and therapy transducer
characteristics, parameter optimization and transducer
design modifications could increase the accuracy of
the treatment. Improving echocardiographic imaging
guidance quality by incorporating a high-resolution
curvilinear imaging transducer in the system would also
be beneficial and is currently under development.
Unsuccessful experiments were more likely to have
overlying limbs, commonly with increased depth to
target. These are somewhat predictable associations, as
bone obstruction and multiple layers of inhomogeneous
media will invariably subject the ultrasound beam
to high degrees of attenuation and aberration before
it reaches the focus. Attenuation makes it difficult
to achieve sufficiently high focal pressures to initiate
cavitation, while acoustic aberration effects may change
the focal pressure profile and increase the pressure
levels of secondary lobes, decreasing targeting accuracy.
To minimize these undesirable effects, choosing an
appropriate acoustic window with minimal bone and
tissue in the pathway is needed prior to treatment. The
use of more powerful therapeutic transducers could also
help compensate for attenuation effects in deep-seated
targets, and aberration correction mechanisms could be
applied to refocus the transducer to an extent by using
phased array systems18,19. However, implementation
for in vivo applications involves significant technical
obstacles that were beyond the scope of this study.
Another possibility is treatment at earlier gestational
stages, when fetal bones are less calcified. The aberration
and attenuation from overlying fetal bone and tissue
would be lower, although higher treatment accuracy
would be required due to the smaller overall size of
the fetus and targets.
An additional challenge is the animal model. Although
sheep are commonly used in non-clinical fetal studies,
particular characteristics of this model have added to
the challenges in our experiments. In humans, the
uterus is located directly beneath the maternal abdomen,
making the fetus accessible and somewhat amenable to
manipulation. In comparison, maneuverability of the fetal
sheep is limited by a bicornuate uterus and multiple
fetuses, while ultrasound access is impaired by overlying
maternal bowel. Fetal lambs also have proportionally
large limbs and hooves, which calcify at a relatively early
gestational age20, limiting the availability of treatment
windows. Fetal wool also increases the likelihood of
prefocal cavitation events. Although these particular
difficulties would not be present in a clinical scenario,
other variables such as movement of the fetus and greater
fetal depth would need to be addressed.
Concern has been raised that fractionated tissue debris
resulting from histotripsy therapy may become hazardous
emboli. An in vitro study has been conducted to assess the
size distribution of these tissue debris particles21. Results
showed no presence of particles > 60 µm in diameter, with
> 80% of the particles < 6 µm. Such particles are unlikely
to form hazardous emboli, because 100-µm mechanical
filters have been successful at preventing embolization
in catheter-based thrombolysis procedures22. However,
it is not known what size particles in a fetus can
cause significant embolization. To further investigate the
embolization risk, we plan to perform postprocedure
diffusion-weighted MRI and pathology analysis of fetal
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organs including the brain, lungs and kidneys in future
experiments.
This feasibility study in the sheep model demonstrated
that extracorporeal histotripsy therapy can induce
localized tissue fractionation in fetal organs. These initial
results demonstrate the potential of this technique, but
it is clear that fetal histotripsy will require further
refinement in order to become a viable tool for fetal
intervention applications. Future studies will focus on
improving the treatment consistency and accuracy in
order to demonstrate the safety and efficacy of the
technology.
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